Kinase Inhibitors Final Exam Flashcards

1
Q

Imantinib drug class

A

type II inhibitor of Abl-TK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what should be tested prior to starting imantinib?

A

Abl gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ponatinib drug class

A

Bcr-Abl inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what should be tested before starting ponatinib

A

Abl gene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Midostaurin drug class

A

1st gen broad kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Midostaurin target

A

FTL3 mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Quizartinib class

A

Type II kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Quizartinib target

A

ITD mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Crenolanib class

A

2nd gen specific kinase inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Crenolanib target

A

FTL3 mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

sirolimus drug class

A

rapamycin analog

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

sirolimus target

A

inhibit mTOR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Alectinib class

A

ALK inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Dabrafenib class

A

BRAF v600 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

trametinib class

A

MEK1 and MEK2 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acalabrutinib class

A

BTK inhibitor

17
Q

Gefitinib classs

A

type 1 EGFR inhibitor

18
Q

Gefitinib resistance mechanism?

A

t790M

19
Q

Lapatinib class

A

TKI for Her2 + EGFR

20
Q

Afatinib class

A

type I EGFR inhibitor/ErbB

21
Q

tucatinib class

A

TKI blocking HER2

22
Q

Osimertinib class

A

kinase inhibitor EGFR

23
Q

what KIs have rash associated as a side effect

A

gefitinib and afatinib

24
Q

when to use osimertinib

A

with a T790M mutation

25
Q

who should not be on trametinib

A

patients who previously received BRAF therpy